SCHEMBL13615763

SCHEMBL13615763

c1cnc(-c2ccc3c4ccccc4c4c5cc(-c6ncccn6)ccc5c5ccccc5c4c3c2)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 3/20 0.39
DYRK1A Q13627 1/20 0.39
ADRB2 P07550 1/20 0.38
PIK3CD O00329 1/20 0.38
PIP5K1C O60331 1/20 0.38
PI4KA P42356 1/20 0.38
PIK3CG P48736 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
CYP2A6 P11509 1/20 0.36
PARP1 P09874 2/20 0.33
CSNK2A1 P68400 1/20 0.33
BRD4 O60885 1/20 0.33
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
THRB P10828 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
VCP P55072 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13615945 1.00 CLK4 (0.39) CLK4DYRK1AADRB2PIK3CDPIP5K1C
SCHEMBL13615913 1.00 CLK4 (0.39) CLK4DYRK1AADRB2PIK3CDPIP5K1C
SCHEMBL13615869 0.94 CLK4 (0.42) CLK4DYRK1AADRB2PIK3CDPIP5K1C
SCHEMBL13616006 0.93 PIK3CA (0.40) CLK4DYRK1AADRB2CYP2A6NPC1
SCHEMBL17229022 0.90 CLK4 (0.42) CLK4DYRK1AADRB2PIK3CDPIP5K1C
SCHEMBL17229023 0.90 CLK4 (0.42) CLK4DYRK1AADRB2PIK3CDPIP5K1C
SCHEMBL13615922 0.85 PARP1 (0.31) PARP1CSNK2A1ALDH1A1CYP1A2THRB
SCHEMBL13615949 0.85 PARP1 (0.31) PARP1CSNK2A1ALDH1A1CYP1A2THRB
SCHEMBL13615765 0.85 PARP1 (0.31) PARP1CSNK2A1ALDH1A1CYP1A2THRB
SCHEMBL12036544 0.82 CLK4 (0.35) CLK4DYRK1AADRB2PIK3CDPIP5K1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090273278-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 CLK4 2580/4885DYRK1A 4574/4885ADRB2 1616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.